Ductal Carcinoma In Situ.
Hematology/oncology clinics of North America
Authors | |
Keywords | |
Abstract | In breast cancer (BC) pathogenesis models, normal cells acquire somatic mutations and there is a stepwise progression from high-risk lesions and ductal carcinoma in situ to invasive cancer. The precancer biology of mammary tissue warrants better characterization to understand how different BC subtypes emerge. Primary methods for BC prevention or risk reduction include lifestyle changes, surgery, and chemoprevention. Surgical intervention for BC prevention involves risk-reducing prophylactic mastectomy, typically performed either synchronously with the treatment of a primary tumor or as a bilateral procedure in high-risk women. Chemoprevention with endocrine therapy carries adherence-limiting toxicity. |
Year of Publication | 2024
|
Journal | Hematology/oncology clinics of North America
|
Volume | 38
|
Issue | 4
|
Pages | 831-849
|
Date Published | 08/2024
|
ISSN | 1558-1977
|
DOI | 10.1016/j.hoc.2024.05.014
|
PubMed ID | 38960507
|
Links |